Skip to content

A Pilot Study to Examine the Impact of a Therapy Dog Intervention on Loneliness and Related Health Outcomes in Vulnerable Populations

A Pilot Study to Examine the Impact of a Therapy Dog Intervention on Loneliness and Related Health Outcomes in Vulnerable Populations

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05089201
Enrollment
72
Registered
2021-10-22
Start date
2021-11-16
Completion date
2024-01-31
Last updated
2024-04-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Anxiety, Depression, Loneliness, Quality of Life

Brief summary

The purpose of this research study is to test whether an animal-assisted interaction (AAI) intervention is better than conversation with another person or treatment as usual for improving mood, anxiety, loneliness, quality of life, and indicators of health care services such as number of hospitalizations, length of hospital stay, and cost of services. Participants will be patients admitted for an inpatient stay at Virginia Commonwealth University Health who meet the study entry requirements.

Detailed description

Participants will be randomly assigned (like the flip of a coin) to receive one of the following interventions: 1. Animal-assisted interaction (a dog-handler team will visit them in their hospital room) 2. Conversational interaction with just participants and the handler 3. Treatment as usual (the regular services patients are currently receiving in the hospital) Participation in this study will last six months. This includes the three days on which participants will receive one of the interventions described above, plus completing some questionnaires online or by phone one month and six months after the baseline visit. These questionnaires will ask questions about pet ownership, relationship with pets participants have had, loneliness, depression, anxiety, health-related quality of life, significant life events in the past year, and social supports. Approximately 180 individuals will participate in this study.

Interventions

A dog-handler team or a handler alone will visit participants with a dog for approximately 20 minutes on 3 consecutive days during their inpatient hospital stay

BEHAVIORALConversational control

A handler alone will visit participants without a dog for approximately 20 minutes on 3 consecutive days during their inpatient hospital stay

Sponsors

Waltham Petcare Science Institute
CollaboratorUNKNOWN
Human Animal Bond Research Institute (HABRI)
CollaboratorUNKNOWN
Virginia Commonwealth University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
BASIC_SCIENCE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* 18 years of age or older * Projected to be admitted to the hospital for the upcoming four days * Speak English * Able to provide consent.

Exclusion criteria

* Fear of, or allergy to, dogs * Documented contact precautions * Cognitive impairment that prevents consent or completion of measures.

Design outcomes

Primary

MeasureTime frameDescription
Number of participants enrolled2 yearsThe number of eligible patients who sigh consent forms and are randomized to a condition
Attrition rate30 monthsNumber of participants who do not complete the full study

Secondary

MeasureTime frameDescription
Change in lonelinessBaseline to 6 monthsLoneliness will be assessed using the 20-item Revised (Version 3) University of California, Los Angeles Loneliness Scale (Rev University of California, Los Angeles - Loneliness Scale).
Change in depressionBaseline to 6 monthsDepressive symptomology will be measured with the 10-item Center for Epidemiological Studies Depression short form (CESD-10) scale.
Change in anxietyBaseline to 6 monthsAnxiety will be measured using the 20-item scale of the State-Trait Anxiety Inventory for Adults (STAI-AD).

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 6, 2026